Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Avraham Pharmaceuticals Ltd
ClinicalTrials.gov Identifier:
NCT01354691
First received: May 1, 2011
Last updated: July 22, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)